DNMT1, DNMT3A, and DNMT3B are overexpressed across several types of cancer lineages, including acute myeloid leukemia (AML), melanoma, breast cancer, colorectal cancer, prostate cancer, and stomach cancer6–11. This evidence concerns the gene DNMT3A and acute myeloid leukemia.